Resources

Un modelo interactivo de Excel que evalúa las ventajas y desventajas de cuatro estrategias del tamizaje del cáncer cérvicouterino y cinco escenarios de tratamiento del precáncer cérvicouterino, al analizar la cantidad de mujeres alcanzadas, la eficacia del enfoque y los costos asociados. Haga clic en el enlace arriba para descargar el archivo Excel. CONSULTE LA NOTA ACLARATORIA EN LA HERRAMIENTA ANTES DE USAR.

An actionable guide to processes and standards for cold chain stakeholders. This document provides guidance and rationale for key stakeholders throughout the cold chain (such as EPI managers, cold chain or vaccine managers, equipment technicians, and health workers) on why and how to maintain accurate cold chain inventories through information, user personas, checklists, and data.

We risk spreading type 2 poliovirus if all mOPV2 vaccine vials are not properly distributed, handled, and deactivated. Vials have gone missing at all levels of the supply chain.Through a comprehensive, ten-month user-centered design process, PATH developed three simple tools to reduce mOPV2 vial loss:Sectioned vial bags to protect vials and improve vial management and tracking.Locking droppers that increase visibility and recognition of mOPV2 while deterring theft.Counting trays for easing the user burden of counting thousands of vials and maintaining accountability through a complex reverse supply chain.

This fact sheet outlines PATH’s role in providing technical assistance to Ethiopia for the planning, implementation, and evaluation of human papillomavirus (HPV) vaccination programs. The PATH HPV vaccine team’s activities are channeled through four primary work streams: Gavi, the Vaccine Alliance application support; program planning and implementation; evaluation; and cervical cancer prevention and control strategies.

SARS-CoV-2: PATH’S RESPONSEFor more than 40 years, PATH has been working to increase access to health interventions, improve quality of care, and achieve health equity. With expertise in global health security, vaccines and immunization, data systems, surveillance and diagnostics under one roof, health experts at PATH can implement holistic solutions. Today, our global team of more than 1,400 is at work in 70 countries, partnering across ministries, governments, and the private sector to develop and roll out lifesaving vaccines, create affordable diagnostic tools, and scale our impact through advocacy and policy efforts.For the COVID-19 outbreak, we are supporting the immediate response by expanding our existing work to help countries be ready to deploy testing, surveillance, mitigation strategies, and solutions to improve health systems. We’re also helping countries identifying health systems strengthening opportunities that will address longer-term concerns.